Patients who have been on this journey with me over the years know my story, but for the new folks, I've been a test dummy and I've been able to track my progress with my darned cirrhotic liver over the years. Here is a chart of my progress through June of 2020. Notice that I've confirmed my progress with both Fibroscan and MRE and I have progressed from a Fibroscan of 21.5 at diagnosis to 9.6 in 2020. Technology is advancing and I recently had an opportunity to get a Velacur test, a new kid on the block offering liver tests.Read more
I was saddened to see our most commonly searched terms within The Wellness League's FindHelp tool. We know the community is fragile and has many health issues but nearly 53% said food was their biggest concern. Imagine that, in a society where excess calories are our biggest driver of long term illness, the unwell struggle with food issues.Read more
We presented a poster of the State of NAFLD/NASH Care in America survey at the annual conference of the AASLD, the American Association for the Study of Liver Disease, last week. If you would like to look at a pdf click on the image below.Read more
Of shoes and ships, of sealing wax and cabbages and kings -- and NAFLD and NASH and how we treat those things.
The Foundation's recent State of NAFLD/NASH Care in America survey highlighted the problem of the lack of understanding of liver disease, even after a visit with a specialist. How do we manage a disease when only 13% of patients understand it even after seeing a specialist?Read more
I want to invite you to a short webinar to introduce you to a key project of the Foundation that is just coming to life.
We all have many needs that are outside the doctor/patient issues we usually talk about. We need patient oriented tools to help with the many non-doctor issues that we face. The Wellness League is our effort to help by making the connection to services easier. If you can't attend go ahead and register and we will send you the recording.Read more
The first I ever heard of NASH was when I was diagnosed with cirrhosis. Couldn’t be I wasn’t a big drinker. As I went through several years of trying to understand my situation and get a proper management program I learned that I could have been warned of this slow moving progressive disease years earlier. I would have had a very good chance to avoid stage 4 liver disease had I just been properly screened. The fact that there are millions just like me who have advancing disease and don’t know it was a key reason for the creation of the Fatty Liver Foundation.Read more
This note is an invitation to a webinar about managing social isolation. It will be September 28th, 12:00 EST.
No one plans to become sick and alone, cut off from meaningful human contact and dying slowly. Humor me for a bit and picture yourself being in solitary confinement and being quite ill. Your cell bars are not metal but the pain and fatigue of chronic illness can become so heavy that breaking free is very difficult.Read more
When you think about how we, as a patient community, live day to day what do you think the top 5 concerns are for this broad and very diverse group of people?
OK Wayne just a darned minute, why should I look at another search engine. I get so sick of all the ads.
Me too, that's why this site is ad free and dedicated to patients. Give it a look at least.Read more
Factores que afectan la preocupante prevalencia de NAFLD y NASH en la población hispana viviendo en los Estados Unidos
¿Por qué la población hispana en los Estados Unidos está siendo altamente afectada por la enfermedad de hígado graso no alcohólica (NAFLD)?
La prevalencia de la enfermedad de hígado graso no alcohólica (NAFLD), es una creciente pandemia afectando a millones de personas en el mundo. Actualmente en los Estados Unidos una de cada tres personas presenta la enfermedad, y desafortunadamente la mayoría no lo sabe.
La población hispana en los Estados Unidos es uno de los grupos principalmente afectados por esta enfermedad. La alta prevalencia de comorbilidades presentes en los hispanos como diabetes, obesidad, hipertensión, hiperlipidemia y enfermedades cardiovasculares son algunos de los principales factores de riesgo asociados con la prevalencia de NAFLD. Los hispanos son uno de los grupos que, si son diagnosticados, presentan estadios de la enfermedad más avanzados y en muchas ocasiones tienen un peor pronóstico.Read more
The patient community is very large, but a broad understanding of the challenges we face is lacking. In peer groups patients often express their opinions of the care they have received. Patient experiences cover the entire range from very good to very bad.
There are existing patient surveys but they are usually driven by academia. I thought it would be a useful and simple thing to capture a view of the patient experience from the patient perspective so it should be simple to get a large group of patients to engage. Seriously, what could make more sense than patients speaking up about their experiences?Read more
We recently offered a flash survey to our members asking for their views on whether the term "fatty" included in the name of nonalcoholic fatty liver disease (NAFLD) was stigmatizing. Here is a link to the results.Read more
I am a member of a committee recommending possible name changes for NAFLD. A key concern of some is that the word fatty is stigmatizing and should be dropped from the name.
This small survey asks the question of you, as a member of the patient community, what you think of this argument? The link below is to a 5 question survey of your views. If we want to be heard we have to speak up. Please help by answering these few questions about stigma.Read more
The CDC reports that over 80% of our people over 65 have two or more chronic health conditions. Big whoop you say, people have problems when they get old. No big deal.
Hold on there buckaroo. That really means poor health and those people mostly don't feel well. Why would you think that is normal? Do you think it is just fine to be unwell for more of your last years than is normal?Read more
International NASH Day is a chance for us to focus attention on the silent epidemic of liver disease that is much deadlier than COVID, but most people don't even know its name. The problem is that it does its damage over decades so we don't notice that we are dying until it is very late in the disease. The statistic that should shock you is that it is the number 4 killer of people in their 40's and 50's. Some of the saddest stories are moms with young kids who wonder what will become of them when the doc says you have cirrhosis and I'm sorry we have no treatment.
Nature/Nurture what really leads to disease? How do we think about risk? Is the goal of individualized precision medicine achievable? Is biology destiny? Can I choose not to kill myself slowly?
These are among the deepest issues facing us as we consider how, as individuals, we choose to live our lives. We never think day to day in these terms, but we are all a different oddly shaped bag of chemistry that somehow persists for a time.Read more
I wonder who the last person to learn that they have cirrhosis following unrelated surgery will be? The problem of diagnosing liver disease during surgery must become a thing of the past. Routine screening and non-invasive testing is the key to eliminating this devastating situation.Read more
This 2022 State of Care Survey is the inaugural annual survey to understand the state of care for NAFLD/NASH as experienced by patients. It will establish a baseline to monitor year-to-year changes in disease management progress. For more information, see the full press release here.Read more
We are launching an important program soon and I will need your support.
The patient community is very large, but a broad understanding of the challenges we face is lacking. There are 100 million of us with liver disease and stories to tell but most are only recognized in the late stages of the disease. We believe that is wrong but a first step is to have the data. We don't have a national benchmark or tracking system to understand the problem broadly or to know if it is getting better or worse. That harms us as patients.
The Fatty Liver Foundation is undertaking a patient focused survey to gather baseline data that many people can use to support advocacy and measure change that will be an annual study of the broad patient population. This note is just to let you know this is coming soon.Read more
When you think about your experiences with healthcare are you pleased?
- Have you ever felt that the medical industry wasn't interested in you?
- Have you struggled with vague symptoms that were mostly ignored?
- Do you think your condition should have been recognized earlier?\